{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Gastrodia elata", "Inflammation", "Rheumatoid arthritis fibroblast-like synoviocytes", "Tumor necrosis factor-\u03b1"]], "OtherID": [], "CitationSubset": ["IM"], "InvestigatorList": [], "SpaceFlightMission": [], "GeneralNote": [], "OtherAbstract": [], "PMID": "27936399", "DateCompleted": {"Year": "2017", "Month": "02", "Day": "13"}, "DateRevised": {"Year": "2022", "Month": "04", "Day": "08"}, "Article": {"ArticleDate": [{"Year": "2016", "Month": "12", "Day": "06"}], "ELocationID": ["10.1016/j.biopha.2016.11.136", "S0753-3322(16)31624-9"], "Language": ["eng"], "Journal": {"ISSN": "1950-6007", "JournalIssue": {"Volume": "85", "PubDate": {"Year": "2017", "Month": "Jan"}}, "Title": "Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie", "ISOAbbreviation": "Biomed Pharmacother"}, "ArticleTitle": "Gastrodia elata attenuates inflammatory response by inhibiting the NF-\u03baB pathway in rheumatoid arthritis fibroblast-like synoviocytes.", "Pagination": {"StartPage": "177", "EndPage": "181", "MedlinePgn": "177-181"}, "Abstract": {"AbstractText": ["Gastrodia elata (GE), which belongs to the Orchidaceae family, was found to possess anti-inflammatory activity. However, the effect of GE on inflammatory response in rheumatoid arthritis fibroblast-like synoviocytes (RA-FLS) remains largely unknown. Thus, the aim of this study was to investigate the effects of GE on tumor necrosis factor-\u03b1 (TNF-\u03b1)-induced inflammatory response in RA-FLS and the underlying molecular mechanism was also explored. Our results demonstrated that GE significantly attenuated TNF-\u03b1-induced IL-6 and IL-8 production in RA-FLS. GE also inhibited TNF-\u03b1-induced MMP-3 and MMP-13 expression in RA-FLS. Furthermore, pretreatment with GE significantly attenuated TNF-\u03b1-induced the expression of p-p65 and I\u03baB\u03b1 degradation in RA-FLS. In conclusion, this study demonstrated for the first time that GE attenuated inflammatory response by inhibiting the NF-\u03baB pathway signaling in RA-FLS. Thus, GE might have a therapeutic potential towards the treatment of RA."], "CopyrightInformation": "Copyright \u00a9 2016. Published by Elsevier Masson SAS."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Orthopaedics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450000, China."}], "LastName": "Li", "ForeName": "Yu", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Orthopaedics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450000, China. Electronic address: wanglm_zz@126.com."}], "LastName": "Wang", "ForeName": "Li-Min", "Initials": "LM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Orthopaedics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450000, China."}], "LastName": "Xu", "ForeName": "Jian-Zhong", "Initials": "JZ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Orthopaedics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450000, China."}], "LastName": "Tian", "ForeName": "Ke", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Orthopaedics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450000, China."}], "LastName": "Gu", "ForeName": "Chen-Xi", "Initials": "CX"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Orthopaedics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450000, China."}], "LastName": "Li", "ForeName": "Zhi-Fu", "Initials": "ZF"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "France", "MedlineTA": "Biomed Pharmacother", "NlmUniqueID": "8213295", "ISSNLinking": "0753-3322"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Inflammatory Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Antirheumatic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "CXCL8 protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "IL6 protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "Inflammation Mediators"}, {"RegistryNumber": "0", "NameOfSubstance": "Interleukin-6"}, {"RegistryNumber": "0", "NameOfSubstance": "Interleukin-8"}, {"RegistryNumber": "0", "NameOfSubstance": "NF-kappa B"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "0", "NameOfSubstance": "RELA protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "Transcription Factor RelA"}, {"RegistryNumber": "0", "NameOfSubstance": "Tumor Necrosis Factor-alpha"}, {"RegistryNumber": "139874-52-5", "NameOfSubstance": "NF-KappaB Inhibitor alpha"}, {"RegistryNumber": "EC 3.4.24.-", "NameOfSubstance": "MMP13 protein, human"}, {"RegistryNumber": "EC 3.4.24.-", "NameOfSubstance": "Matrix Metalloproteinase 13"}, {"RegistryNumber": "EC 3.4.24.17", "NameOfSubstance": "MMP3 protein, human"}, {"RegistryNumber": "EC 3.4.24.17", "NameOfSubstance": "Matrix Metalloproteinase 3"}], "MeshHeadingList": [{"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Anti-Inflammatory Agents"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Antirheumatic Agents"}, {"QualifierName": ["drug therapy", "genetics", "metabolism", "pathology"], "DescriptorName": "Arthritis, Rheumatoid"}, {"QualifierName": [], "DescriptorName": "Dose-Response Relationship, Drug"}, {"QualifierName": ["drug effects", "metabolism", "pathology"], "DescriptorName": "Fibroblasts"}, {"QualifierName": ["chemistry"], "DescriptorName": "Gastrodia"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["metabolism"], "DescriptorName": "Inflammation Mediators"}, {"QualifierName": ["metabolism"], "DescriptorName": "Interleukin-6"}, {"QualifierName": ["metabolism"], "DescriptorName": "Interleukin-8"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "Matrix Metalloproteinase 13"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "Matrix Metalloproteinase 3"}, {"QualifierName": ["metabolism"], "DescriptorName": "NF-KappaB Inhibitor alpha"}, {"QualifierName": ["metabolism"], "DescriptorName": "NF-kappa B"}, {"QualifierName": [], "DescriptorName": "Phosphorylation"}, {"QualifierName": [], "DescriptorName": "Phytotherapy"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Proteolysis"}, {"QualifierName": ["drug effects"], "DescriptorName": "Signal Transduction"}, {"QualifierName": ["drug effects", "metabolism", "pathology"], "DescriptorName": "Synovial Membrane"}, {"QualifierName": [], "DescriptorName": "Time Factors"}, {"QualifierName": ["metabolism"], "DescriptorName": "Transcription Factor RelA"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Tumor Necrosis Factor-alpha"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2016", "Month": "9", "Day": "16"}, {"Year": "2016", "Month": "11", "Day": "16"}, {"Year": "2016", "Month": "11", "Day": "28"}, {"Year": "2016", "Month": "12", "Day": "10", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "2", "Day": "14", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "12", "Day": "10", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["27936399", "10.1016/j.biopha.2016.11.136", "S0753-3322(16)31624-9"]}}], "PubmedBookArticle": []}